▶ 調査レポート

世界の不眠症治療薬市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Insomnia Treatment Drugs Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の不眠症治療薬市場規模・現状・予測(2021年-2027年) / Global Insomnia Treatment Drugs Market Size, Status and Forecast 2021-2027 / QFJ1-5803資料のイメージです。• レポートコード:QFJ1-5803
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、不眠症治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(処方箋睡眠補助薬、店頭販売(OTC)睡眠補助薬)、用途別市場規模(病院、薬局、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・不眠症治療薬の市場動向
・企業の競争状況、市場シェア
・不眠症治療薬の種類別市場規模と予測2016-2027(処方箋睡眠補助薬、店頭販売(OTC)睡眠補助薬)
・不眠症治療薬の用途別市場規模と予測2016-2027(病院、薬局、その他)
・不眠症治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・不眠症治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・不眠症治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・不眠症治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・不眠症治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(F.Hoffman La-Roche AG、Merck & Co. Inc.、Mylan N.V.、Pfizer, Inc.、Pernix Therapeutics、Sanofi S.A.、Takeda Pharmaceutical Company Ltd.、Sumitomo Dainippon Pharma Co., Ltd、Teva Pharmaceutical Industries Ltd.、Vanda Pharmaceuticals, Inc.)
・結論

Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.

Market Analysis and Insights: Global Insomnia Treatment Drugs Market
The global Insomnia Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Insomnia Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Insomnia Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Insomnia Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Insomnia Treatment Drugs market.

Global Insomnia Treatment Drugs Scope and Market Size
Insomnia Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Insomnia Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prescription Sleep Aids
Over the Counter (OTC) Sleep Aids

Segment by Application
Hospital
Pharmacy
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
F.Hoffman La-Roche AG
Merck & Co. Inc.
Mylan N.V.
Pfizer, Inc.
Pernix Therapeutics
Sanofi S.A.
Takeda Pharmaceutical Company Ltd.
Sumitomo Dainippon Pharma Co., Ltd
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals, Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prescription Sleep Aids
1.2.3 Over the Counter (OTC) Sleep Aids
1.3 Market by Application
1.3.1 Global Insomnia Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Insomnia Treatment Drugs Market Perspective (2016-2027)
2.2 Insomnia Treatment Drugs Growth Trends by Regions
2.2.1 Insomnia Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Insomnia Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Insomnia Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Insomnia Treatment Drugs Industry Dynamic
2.3.1 Insomnia Treatment Drugs Market Trends
2.3.2 Insomnia Treatment Drugs Market Drivers
2.3.3 Insomnia Treatment Drugs Market Challenges
2.3.4 Insomnia Treatment Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Insomnia Treatment Drugs Players by Revenue
3.1.1 Global Top Insomnia Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Insomnia Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Insomnia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Insomnia Treatment Drugs Revenue
3.4 Global Insomnia Treatment Drugs Market Concentration Ratio
3.4.1 Global Insomnia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Treatment Drugs Revenue in 2020
3.5 Insomnia Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Insomnia Treatment Drugs Product Solution and Service
3.7 Date of Enter into Insomnia Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Insomnia Treatment Drugs Breakdown Data by Type
4.1 Global Insomnia Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Insomnia Treatment Drugs Forecasted Market Size by Type (2022-2027)

5 Insomnia Treatment Drugs Breakdown Data by Application
5.1 Global Insomnia Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Insomnia Treatment Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Insomnia Treatment Drugs Market Size (2016-2027)
6.2 North America Insomnia Treatment Drugs Market Size by Type
6.2.1 North America Insomnia Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Insomnia Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Insomnia Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Insomnia Treatment Drugs Market Size by Application
6.3.1 North America Insomnia Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Insomnia Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Insomnia Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Insomnia Treatment Drugs Market Size by Country
6.4.1 North America Insomnia Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Insomnia Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Insomnia Treatment Drugs Market Size (2016-2027)
7.2 Europe Insomnia Treatment Drugs Market Size by Type
7.2.1 Europe Insomnia Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Insomnia Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Insomnia Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Insomnia Treatment Drugs Market Size by Application
7.3.1 Europe Insomnia Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Insomnia Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Insomnia Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Insomnia Treatment Drugs Market Size by Country
7.4.1 Europe Insomnia Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Insomnia Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Insomnia Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Insomnia Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Insomnia Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Insomnia Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Insomnia Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Insomnia Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Insomnia Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Insomnia Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Insomnia Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Insomnia Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Insomnia Treatment Drugs Market Size (2016-2027)
9.2 Latin America Insomnia Treatment Drugs Market Size by Type
9.2.1 Latin America Insomnia Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Insomnia Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Insomnia Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Insomnia Treatment Drugs Market Size by Application
9.3.1 Latin America Insomnia Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Insomnia Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Insomnia Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Insomnia Treatment Drugs Market Size by Country
9.4.1 Latin America Insomnia Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Insomnia Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Insomnia Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Insomnia Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Insomnia Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Insomnia Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Insomnia Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Insomnia Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Insomnia Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Insomnia Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Insomnia Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Insomnia Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F.Hoffman La-Roche AG
11.1.1 F.Hoffman La-Roche AG Company Details
11.1.2 F.Hoffman La-Roche AG Business Overview
11.1.3 F.Hoffman La-Roche AG Insomnia Treatment Drugs Introduction
11.1.4 F.Hoffman La-Roche AG Revenue in Insomnia Treatment Drugs Business (2016-2021)
11.1.5 F.Hoffman La-Roche AG Recent Development
11.2 Merck & Co. Inc.
11.2.1 Merck & Co. Inc. Company Details
11.2.2 Merck & Co. Inc. Business Overview
11.2.3 Merck & Co. Inc. Insomnia Treatment Drugs Introduction
11.2.4 Merck & Co. Inc. Revenue in Insomnia Treatment Drugs Business (2016-2021)
11.2.5 Merck & Co. Inc. Recent Development
11.3 Mylan N.V.
11.3.1 Mylan N.V. Company Details
11.3.2 Mylan N.V. Business Overview
11.3.3 Mylan N.V. Insomnia Treatment Drugs Introduction
11.3.4 Mylan N.V. Revenue in Insomnia Treatment Drugs Business (2016-2021)
11.3.5 Mylan N.V. Recent Development
11.4 Pfizer, Inc.
11.4.1 Pfizer, Inc. Company Details
11.4.2 Pfizer, Inc. Business Overview
11.4.3 Pfizer, Inc. Insomnia Treatment Drugs Introduction
11.4.4 Pfizer, Inc. Revenue in Insomnia Treatment Drugs Business (2016-2021)
11.4.5 Pfizer, Inc. Recent Development
11.5 Pernix Therapeutics
11.5.1 Pernix Therapeutics Company Details
11.5.2 Pernix Therapeutics Business Overview
11.5.3 Pernix Therapeutics Insomnia Treatment Drugs Introduction
11.5.4 Pernix Therapeutics Revenue in Insomnia Treatment Drugs Business (2016-2021)
11.5.5 Pernix Therapeutics Recent Development
11.6 Sanofi S.A.
11.6.1 Sanofi S.A. Company Details
11.6.2 Sanofi S.A. Business Overview
11.6.3 Sanofi S.A. Insomnia Treatment Drugs Introduction
11.6.4 Sanofi S.A. Revenue in Insomnia Treatment Drugs Business (2016-2021)
11.6.5 Sanofi S.A. Recent Development
11.7 Takeda Pharmaceutical Company Ltd.
11.7.1 Takeda Pharmaceutical Company Ltd. Company Details
11.7.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.7.3 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Introduction
11.7.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Treatment Drugs Business (2016-2021)
11.7.5 Takeda Pharmaceutical Company Ltd. Recent Development
11.8 Sumitomo Dainippon Pharma Co., Ltd
11.8.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
11.8.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.8.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Introduction
11.8.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Treatment Drugs Business (2016-2021)
11.8.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Teva Pharmaceutical Industries Ltd. Company Details
11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.9.3 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Introduction
11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Treatment Drugs Business (2016-2021)
11.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.10 Vanda Pharmaceuticals, Inc.
11.10.1 Vanda Pharmaceuticals, Inc. Company Details
11.10.2 Vanda Pharmaceuticals, Inc. Business Overview
11.10.3 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Introduction
11.10.4 Vanda Pharmaceuticals, Inc. Revenue in Insomnia Treatment Drugs Business (2016-2021)
11.10.5 Vanda Pharmaceuticals, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Insomnia Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prescription Sleep Aids
Table 3. Key Players of Over the Counter (OTC) Sleep Aids
Table 4. Global Insomnia Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Insomnia Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Insomnia Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Insomnia Treatment Drugs Market Share by Regions (2016-2021)
Table 8. Global Insomnia Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Insomnia Treatment Drugs Market Share by Regions (2022-2027)
Table 10. Insomnia Treatment Drugs Market Trends
Table 11. Insomnia Treatment Drugs Market Drivers
Table 12. Insomnia Treatment Drugs Market Challenges
Table 13. Insomnia Treatment Drugs Market Restraints
Table 14. Global Insomnia Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Insomnia Treatment Drugs Market Share by Players (2016-2021)
Table 16. Global Top Insomnia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Treatment Drugs as of 2020)
Table 17. Ranking of Global Top Insomnia Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Insomnia Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Insomnia Treatment Drugs Product Solution and Service
Table 21. Date of Enter into Insomnia Treatment Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Insomnia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Insomnia Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Insomnia Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Insomnia Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Insomnia Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Insomnia Treatment Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Insomnia Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Insomnia Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Insomnia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Insomnia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Insomnia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Insomnia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Insomnia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Insomnia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Insomnia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Insomnia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Insomnia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Insomnia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Insomnia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Insomnia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Insomnia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Insomnia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Insomnia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Insomnia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Insomnia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Insomnia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Insomnia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Insomnia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Insomnia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Insomnia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Insomnia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Insomnia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Insomnia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Insomnia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. F.Hoffman La-Roche AG Company Details
Table 62. F.Hoffman La-Roche AG Business Overview
Table 63. F.Hoffman La-Roche AG Insomnia Treatment Drugs Product
Table 64. F.Hoffman La-Roche AG Revenue in Insomnia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 65. F.Hoffman La-Roche AG Recent Development
Table 66. Merck & Co. Inc. Company Details
Table 67. Merck & Co. Inc. Business Overview
Table 68. Merck & Co. Inc. Insomnia Treatment Drugs Product
Table 69. Merck & Co. Inc. Revenue in Insomnia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 70. Merck & Co. Inc. Recent Development
Table 71. Mylan N.V. Company Details
Table 72. Mylan N.V. Business Overview
Table 73. Mylan N.V. Insomnia Treatment Drugs Product
Table 74. Mylan N.V. Revenue in Insomnia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 75. Mylan N.V. Recent Development
Table 76. Pfizer, Inc. Company Details
Table 77. Pfizer, Inc. Business Overview
Table 78. Pfizer, Inc. Insomnia Treatment Drugs Product
Table 79. Pfizer, Inc. Revenue in Insomnia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 80. Pfizer, Inc. Recent Development
Table 81. Pernix Therapeutics Company Details
Table 82. Pernix Therapeutics Business Overview
Table 83. Pernix Therapeutics Insomnia Treatment Drugs Product
Table 84. Pernix Therapeutics Revenue in Insomnia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 85. Pernix Therapeutics Recent Development
Table 86. Sanofi S.A. Company Details
Table 87. Sanofi S.A. Business Overview
Table 88. Sanofi S.A. Insomnia Treatment Drugs Product
Table 89. Sanofi S.A. Revenue in Insomnia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 90. Sanofi S.A. Recent Development
Table 91. Takeda Pharmaceutical Company Ltd. Company Details
Table 92. Takeda Pharmaceutical Company Ltd. Business Overview
Table 93. Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Product
Table 94. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 95. Takeda Pharmaceutical Company Ltd. Recent Development
Table 96. Sumitomo Dainippon Pharma Co., Ltd Company Details
Table 97. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 98. Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 99. Sumitomo Dainippon Pharma Co., Ltd Recent Development
Table 100. Teva Pharmaceutical Industries Ltd. Company Details
Table 101. Teva Pharmaceutical Industries Ltd. Business Overview
Table 102. Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Product
Table 103. Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 104. Teva Pharmaceutical Industries Ltd. Recent Development
Table 105. Vanda Pharmaceuticals, Inc. Company Details
Table 106. Vanda Pharmaceuticals, Inc. Business Overview
Table 107. Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Product
Table 108. Vanda Pharmaceuticals, Inc. Revenue in Insomnia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 109. Vanda Pharmaceuticals, Inc. Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Insomnia Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. Prescription Sleep Aids Features
Figure 3. Over the Counter (OTC) Sleep Aids Features
Figure 4. Global Insomnia Treatment Drugs Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Pharmacy Case Studies
Figure 7. Others Case Studies
Figure 8. Insomnia Treatment Drugs Report Years Considered
Figure 9. Global Insomnia Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Insomnia Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Insomnia Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Insomnia Treatment Drugs Market Share by Regions (2022-2027)
Figure 13. Global Insomnia Treatment Drugs Market Share by Players in 2020
Figure 14. Global Top Insomnia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Treatment Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Insomnia Treatment Drugs Revenue in 2020
Figure 16. Global Insomnia Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Insomnia Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Insomnia Treatment Drugs Market Share by Type (2016-2027)
Figure 20. North America Insomnia Treatment Drugs Market Share by Application (2016-2027)
Figure 21. North America Insomnia Treatment Drugs Market Share by Country (2016-2027)
Figure 22. United States Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Insomnia Treatment Drugs Market Share by Type (2016-2027)
Figure 26. Europe Insomnia Treatment Drugs Market Share by Application (2016-2027)
Figure 27. Europe Insomnia Treatment Drugs Market Share by Country (2016-2027)
Figure 28. Germany Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Insomnia Treatment Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Insomnia Treatment Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Insomnia Treatment Drugs Market Share by Region (2016-2027)
Figure 38. China Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Insomnia Treatment Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Insomnia Treatment Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Insomnia Treatment Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Insomnia Treatment Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Insomnia Treatment Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Insomnia Treatment Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Insomnia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. F.Hoffman La-Roche AG Revenue Growth Rate in Insomnia Treatment Drugs Business (2016-2021)
Figure 58. Merck & Co. Inc. Revenue Growth Rate in Insomnia Treatment Drugs Business (2016-2021)
Figure 59. Mylan N.V. Revenue Growth Rate in Insomnia Treatment Drugs Business (2016-2021)
Figure 60. Pfizer, Inc. Revenue Growth Rate in Insomnia Treatment Drugs Business (2016-2021)
Figure 61. Pernix Therapeutics Revenue Growth Rate in Insomnia Treatment Drugs Business (2016-2021)
Figure 62. Sanofi S.A. Revenue Growth Rate in Insomnia Treatment Drugs Business (2016-2021)
Figure 63. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Treatment Drugs Business (2016-2021)
Figure 64. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Insomnia Treatment Drugs Business (2016-2021)
Figure 65. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Insomnia Treatment Drugs Business (2016-2021)
Figure 66. Vanda Pharmaceuticals, Inc. Revenue Growth Rate in Insomnia Treatment Drugs Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed